Shanghai Virogin Biotech Co., Ltd.
2 clinical trials · Sponsor
◉ Watch Shanghai Virogin Biotech Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Biologic Effect of VG2062 in Patients With Solid Tumors (NCT07262164) | Shanghai Virogin Biotech Co., Ltd. | 2026-03-18 |
| A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Biologic Effect of VG2025 in Patients with Solid Tumors (NCT05477849) | Shanghai Virogin Biotech Co., Ltd. | 2022-08-23 |
Track Shanghai Virogin Biotech Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.